MYC and medulloblastoma: Specifically, the BRD4 inhibitor, JQ1, was shown to reduce the proliferation of group 3 medulloblastoma cells with MYC amplification and to prolong the survival of mouse models with tumors having these characteristics [103,104] (Figure 4).